Bashir Lawal

August 3, 2022

Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration

Abstract Papillary thyroid carcinoma (PTC) is the most prevalent endocrine malignancy with a steadily increasing global incidence in recent decades.…

September 2, 2021

MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types

Keywords: MXD3, Immuno-oncology, Immunotherapy, Chemotherapy, Gene expression profiling, Immune-cell infiltration, T-cell exclusion, Genetic and epigenetic alterations Authors: Szu-Yuan Wu, Kuan-Chou…

August 16, 2021

Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance

Abstract Simple Summary: We used multi-omics approaches to evaluate the association of complement signature C3/C5/C3AR1/C5AR1 with tumor immune phenotypes and…

March 26, 2021

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications

Abstract Background: The application of computational and multi-omics approaches has aided our understanding of carcinogenesis and the development of therapeutic…